The bright and the dark sides of activin in wound healing and cancer

Journal of Cell Science

Volumn 125, Issue 17, 2012, Pages 3929-3937

  Antsiferova, Maria ^a   Werner, Sabine ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Activin; Cancer; Tumour microenvironment; Wound healing

Indexed keywords

ACTIVIN; CALCITONIN GENE RELATED PEPTIDE; MUTAGENIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

BONE DISEASE; BONE DISRUPTION; CANCER GROWTH; CANCER SUSCEPTIBILITY; GENE OVEREXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MUSCLE ATROPHY; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TARGETING; SCAR; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN FIBROSIS; SKIN INJURY; TUMOR MICROENVIRONMENT; WOUND HEALING;

ACTIVINS; ANIMALS; CICATRIX; FIBROSIS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84869140926     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.094789     Document Type: Note

References (82)

1. Antsiferova, M., Klatte, J. E., Bodó, E., Paus, R., Jorcano, J. L., Matzuk, M. M., Werner, S. and Kögel, H. (2009). Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair. Lab. Invest. 89, 131-141.
2. Antsiferova, M., Huber, M., Meyer, M., Piwko-Czuchra, A., Ramadan, T., MacLeod, A. S., Havran, W. L., Dummer, R., Hohl, D. and Werner, S. (2011). Activin enhances skin tumourigenesis and malignant progression by inducing a protumourigenic immune cell response. Nat Commun 2, 576.
3. Aoki, F., Kurabayashi, M., Hasegawa, Y. and Kojima, I. (2005). Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am. J. Respir. Crit. Care Med. 172, 713-720.
4. Arnoux, V., Come, C., Kusewitt, D. F., Hudson, L. and Savagner, P. (2005). Cutaneous wound reepithelialization: a partial and reversible EMT. In Rise and Fall of Epithelial Phenotype: Concepts of Epithelial-Mesenchymal Transition (ed. P. Savagner), pp. 111-134. New York: Springer.
5. Bamberger, C., Schärer, A., Antsiferova, M., Tychsen, B., Pankow, S., Müller, M., Rülicke, T., Paus, R. and Werner, S. (2005). Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. Am. J. Pathol. 167, 733-747.
6. Benny Klimek, M. E., Aydogdu, T., Link, M. J., Pons, M., Koniaris, L. G. and Zimmers, T. A. (2010). Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem. Biophys. Res. Commun. 391, 1548-1554.
7. Breit, S., Ashman, K., Wilting, J., Rössler, J., Hatzi, E., Fotsis, T. and Schweigerer, L. (2000). The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res. 60, 4596-4601.
8. Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K., Chi, J. T., van de Rijn, M., Botstein, D. and Brown, P. O. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2, E7.
9. Chang, K. P., Kao, H. K., Liang, Y., Cheng, M. H., Chang, Y. L., Liu, S. C., Lin, Y. C., Ko, T. Y., Lee, Y. S., Tsai, C. L. et al. (2010). Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression. Ann. Surg. Oncol. 17, 1945-1956.
10. Chantry, A. D., Heath, D., Mulivor, A. W., Pearsall, S., Baud'huin, M., Coulton, L., Evans, H., Abdul, N., Werner, E. D., Bouxsein, M. L. et al. (2010). Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo. J. Bone Miner. Res. 25, 2633-2646.
11. Chen, Y. G., Wang, Q., Lin, S. L., Chang, C. D., Chuang, J. and Ying, S. Y. (2006). Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp. Biol. Med. (Maywood) 231, 534-544.
12. Clark, R. A., Huang, S. J., Murphy, G. F., Mollet, I. G., Hijnen, D., Muthukuru, M., Schanbacher, C. F., Edwards, V., Miller, D. M., Kim, J. E. et al. (2008). Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J. Exp. Med. 205, 2221-2234.
13. Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H. and Hanahan, D. (1999). Inflammatory mast cells upregulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382-1397.
14. Cruise, B. A., Xu, P. and Hall, A. K. (2004). Wounds increase activin in skin and a vasoactive neuropeptide in sensory ganglia. Dev. Biol. 271, 1-10.
15. de Visser, K. E., Eichten, A. and Coussens, L. M. (2006). Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24-37.
16. Dvorak, H. F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659.
17. Egeblad, M., Nakasone, E. S. and Werb, Z. (2010). Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884-901.
18. Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. and Licona-Limón, P. (2010). The polarization of immune cells in the tumour environment by TGFbeta. Nat. Rev. Immunol. 10, 554-567.
19. Fumagalli, M., Musso, T., Vermi, W., Scutera, S., Daniele, R., Alotto, D., Cambieri, I., Ostorero, A., Gentili, F., Caposio, P. et al. (2007). Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp. Dermatol. 16, 600-610.
20. Funaba, M., Ikeda, T., Ogawa, K., Murakami, M. and Abe, M. (2003). Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration. J. Leukoc. Biol. 73, 793-801.
21. Gold, E. and Risbridger, G. (2012). Activins and activin antagonists in the prostate and prostate cancer. Mol. Cell. Endocrinol. 359, 107-112.
22. Gratchev, A., Kzhyshkowska, J., Köthe, K., Muller-Molinet, I., Kannookadan, S., Utikal, J. and Goerdt, S. (2006). Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 211, 473-486.
23. Haddow, A. (1974). Addendum to "molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing"? Adv. Cancer Res. 20, 343-366.
24. Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
25. Harrison, C. A., Gray, P. C., Vale, W. W. and Robertson, D. M. (2005). Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol. Metab. 16, 73-78.
26. Harrison, C. A., Al-Musawi, S. L. and Walton, K. L. (2011). Prodomains regulate the synthesis, extracellular localisation and activity of TGF-b superfamily ligands. Growth Factors 29, 174-186.
27. Hedger, M. P., Winnall, W. R., Phillips, D. J. and de Kretser, D. M. (2011). The regulation and functions of activin and follistatin in inflammation and immunity. Vitam. Horm. 85, 255-297.
28. Huber, S., Stahl, F. R., Schrader, J., Lüth, S., Presser, K., Carambia, A., Flavell, R. A., Werner, S., Blessing, M., Herkel, J. et al. (2009). Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells. J. Immunol. 182, 4633-4640.
29. Hübner, G. and Werner, S. (1996). Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp. Cell Res. 228, 106-113.
30. Hübner, G., Hu, Q., Smola, H. and Werner, S. (1996). Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev. Biol. 173, 490-498.
31. Hübner, G., Alzheimer, C. and Werner, S. (1999). Activin: a novel player in tissue repair processes. Histol. Histopathol. 14, 295-304.
32. Incorvaia, L., Badalamenti, G., Rini, G., Arcara, C., Fricano, S., Sferrazza, C., Di Trapani, D., Gebbia, N. and Leto, G. (2007). MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res. 27, 1519-1525.
33. Jaźwińska, A., Badakov, R. and Keating, M. T. (2007). Activin-betaA signaling is required for zebrafish fin regeneration. Curr. Biol. 17, 1390-1395.
34. Kaneda, H., Arao, T., Matsumoto, K., De Velasco, M. A., Tamura, D., Aomatsu, K., Kudo, K., Sakai, K., Nagai, T., Fujita, Y. et al. (2011). Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer. Br. J. Cancer 105, 1210-1217.
35. Kjartansson, J. and Dalsgaard, C. J. (1987). Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat. Eur. J. Pharmacol. 142, 355-358.
36. Krneta, J., Kroll, J., Alves, F., Prahst, C., Sananbenesi, F., Dullin, C., Kimmina, S., Phillips, D. J. and Augustin, H. G. (2006). Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors. Cancer Res. 66, 5686-5695.
37. Leto, G., Incorvaia, L., Badalamenti, G., Tumminello, F. M., Gebbia, N., Flandina, C., Crescimanno, M. and Rini, G. (2006). Activin A circulating levels in patients with bone metastasis from breast or prostate cancer. Clin. Exp. Metastasis 23, 117-122.
38. Loke, P., Gallagher, I., Nair, M. G., Zang, X., Brombacher, F., Mohrs, M., Allison, J. P. and Allen, J. E. (2007). Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J. Immunol. 179, 3926-3936.
39. Makanji, Y., Walton, K. L., Chan, K. L., Gregorevic, P., Robertson, D. M. and Harrison, C. A. (2011). Generation of a specific activin antagonist by modification of the activin A propeptide. Endocrinology 152, 3758-3768.
40. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. and Sica, A. (2002). Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
41. McCarthy, S. A. and Bicknell, R. (1993). Inhibition of vascular endothelial cell growth by activin-A. J. Biol. Chem. 268, 23066-23071.
42. Modi, B. G., Neustadter, J., Binda, E., Lewis, J., Filler, R. B., Roberts, S. J., Kwong, B. Y., Reddy, S., Overton, J. D., Galan, A. et al. (2012). Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 335, 104-108.
43. Mukhopadhyay, A., Chan, S. Y., Lim, I. J., Phillips, D. J. and Phan, T. T. (2007). The role of the activin system in keloid pathogenesis. Am. J. Physiol. Cell Physiol. 292, C1331-C1338.
44. Munz, B., Smola, H., Engelhardt, F., Bleuel, K., Brauchle, M., Lein, I., Evans, L. W., Huylebroeck, D., Balling, R. and Werner, S. (1999). Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J. 18, 5205-5215.
45. Musso, T., Scutera, S., Vermi, W., Daniele, R., Fornaro, M., Castagnoli, C., Alotto, D., Ravanini, M., Cambieri, I., Salogni, L. et al. (2008). Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS ONE 3, e3271.
46. Nüsing, R. M. and Barsig, J. (1999). Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br. J. Pharmacol. 127, 919-926.
47. Ogawa, K. and Funaba, M. (2011). Activin in humoral immune responses. Vitam. Horm. 85, 235-253.
48. Ogawa, K., Funaba, M., Chen, Y. and Tsujimoto, M. (2006). Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J. Immunol. 177, 6787-6794.
49. Ogino, H., Yano, S., Kakiuchi, S., Muguruma, H., Ikuta, K., Hanibuchi, M., Uehara, H., Tsuchida, K., Sugino, H. and Sone, S. (2008). Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin. Cancer Res. 14, 660-667.
50. Panopoulou, E., Murphy, C., Rasmussen, H., Bagli, E., Rofstad, E. K. and Fotsis, T. (2005). Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms. Cancer Res. 65, 1877-1886.
51. Patella, S., Phillips, D. J., Tchongue, J., de Kretser, D. M. and Sievert, W. (2006). Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G137-G144.
52. Petraglia, F., Sacerdote, P., Cossarizza, A., Angioni, S., Genazzani, A. D., Franceschi, C., Muscettola, M. and Grasso, G. (1991). Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. J. Clin. Endocrinol. Metab. 72, 496-502.
53. Poulaki, V., Mitsiades, N., Kruse, F. E., Radetzky, S., Iliaki, E., Kirchhof, B. and Joussen, A. M. (2004). Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression. Am. J. Pathol. 164, 1293-1302.
54. Risbridger, G. P., Schmitt, J. F. and Robertson, D. M. (2001). Activins and inhibins in endocrine and other tumors. Endocr. Rev. 22, 836-858.
55. Robson, N. C., Phillips, D. J., McAlpine, T., Shin, A., Svobodova, S., Toy, T., Pillay, V., Kirkpatrick, N., Zanker, D., Wilson, K. et al. (2008). Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111, 2733-2743.
56. Robson, N. C., Wei, H., McAlpine, T., Kirkpatrick, N., Cebon, J. and Maraskovsky, E. (2009). Activin-A attenuates several human natural killer cell functions. Blood 113, 3218-3225.
57. Salogni, L., Musso, T., Bosisio, D., Mirolo, M., Jala, V. R., Haribabu, B., Locati, M. and Sozzani, S. (2009). Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. Blood 113, 5848-5856.
58. Schäfer, M. and Werner, S. (2008). Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol. 9, 628-638.
59. Schramm, A., von Schuetz, V., Christiansen, H., Havers, W., Papoutsi, M., Wilting, J. and Schweigerer, L. (2005). High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome. Oncogene 24, 680-687.
60. Scutera, S., Riboldi, E., Daniele, R., Elia, A. R., Fraone, T., Castagnoli, C., Giovarelli, M., Musso, T. and Sozzani, S. (2008). Production and function of activin A in human dendritic cells. Eur. Cytokine Netw. 19, 60-68.
61. Seishima, M., Nojiri, M., Esaki, C., Yoneda, K., Eto, Y. and Kitajima, Y. (1999). Activin A induces terminal differentiation of cultured human keratinocytes. J. Invest. Dermatol. 112, 432-436.
62. Semitekolou, M., Alissafi, T., Aggelakopoulou, M., Kourepini, E., Kariyawasam, H. H., Kay, A. B., Robinson, D. S., Lloyd, C. M., Panoutsakopoulou, V. and Xanthou, G. (2009). Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J. Exp. Med. 206, 1769-1785.
63. Shoham, T., Sternberg, D., Brosh, N., Krupsky, M., Barda-Saad, M. and Zipori, D. (2001). The promotion of plasmacytoma tumor growth by mesenchymal stroma is antagonized by basic fibroblast growth factor induced activin A. Leukemia 15, 1102-1110.
64. Sierra-Filardi, E., Puig-Kröger, A., Blanco, F. J., Nieto, C., Bragado, R., Palomero, M. I., Bernabéu, C., Vega, M. A. and Corbí, A. L. (2011). Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117, 5092-5101.
65. Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B. and Evan, G. I. (2007). Mast cells are required for angiogenesis and macroscopic expansion of Mycinduced pancreatic islet tumors. Nat. Med. 13, 1211-1218.
66. Stoitzner, P., Stössel, H., Wankell, M., Hofer, S., Heufler, C., Werner, S. and Romani, N. (2005). Langerhans cells are strongly reduced in the skin of transgenic mice overexpressing follistatin in the epidermis. Eur. J. Cell Biol. 84, 733-741.
67. Tan, T. T. and Coussens, L. M. (2007). Humoral immunity, inflammation and cancer. Curr. Opin. Immunol. 19, 209-216.
68. Tang, Q. and Bluestone, J. A. (2008). The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239-244.
69. ten Dijke, P. and Hill, C. S. (2004). New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29, 265-273.
70. Tiedemann, H., Lottspeich, F., Davids, M., Knöchel, S., Hoppe, P. and Tiedemann, H. (1992). The vegetalizing factor. A member of the evolutionarily highly conserved activin family. FEBS Lett. 300, 123-126.
71. Tsuchida, K., Nakatani, M., Uezumi, A., Murakami, T. and Cui, X. (2008). Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer. Endocr. J. 55, 11-21.
72. Vallet, S., Mukherjee, S., Vaghela, N., Hideshima, T., Fulciniti, M., Pozzi, S., Santo, L., Cirstea, D., Patel, K., Sohani, A. R. et al. (2010). Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc. Natl. Acad. Sci. USA 107, 5124-5129.
73. Virchow, R. (1863). Aetiologie der neoplastischen Geschwulste/Pathogenie der neoplastischen Geschwulste. Berlin: Verlag von August Hirschwald. Wacker, I., Sachs, M., Knaup, K., Wiesener, M., Weiske, J., Huber, O., Akçetin, Z. and Behrens, J. (2009). Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor. Mol. Cell. Biol. 29, 1707-1718.
74. Wada, W., Kuwano, H., Hasegawa, Y. and Kojima, I. (2004). The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 145, 2753-2759.
75. Wankell, M., Munz, B., Hübner, G., Hans, W., Wolf, E., Goppelt, A. and Werner, S. (2001). Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J. 20, 5361-5372.
76. Werner, S. and Grose, R. (2003). Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83, 835-870.
77. Werner, S. and Alzheimer, C. (2006). Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 17, 157-171.
78. Yamashita, N., Nakajima, T., Takahashi, H., Kaneoka, H., Mizushima, Y. and Sakane, T. (1993). Effects of activin A on IgE synthesis and cytokine production by human peripheral mononuclear cells. Clin. Exp. Immunol. 94, 214-219.
79. Yoshinaga, K., Yamashita, K., Mimori, K., Tanaka, F., Inoue, H. and Mori, M. (2008). Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells. Ann. Surg. Oncol. 15, 96-103.
80. Zhang, M., Liu, N. Y., Wang, X. E., Chen, Y. H., Li, Q. L., Lu, K. R., Sun, L., Jia, Q., Zhang, L. and Zhang, L. (2011). Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway. PLoS ONE 6, e25143.
81. Zhang, Z., Zheng, J., Zhao, Y., Li, G., Batres, Y., Luo, M., Wan, M. and Ying, S. (1997). Overexpression of activin A inhibits growth, induces apoptosis, and suppresses tumorigenicity in an androgen-sensitive human prostate cancer cell line LNCaP. Int. J. Oncol. 11, 727-736.
82. Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T., Simonet, W. S. et al. (2010). Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531-543.